Steven P. Coen - 16 Oct 2026 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Oct 2026, 16:07:04 UTC
Prior SEC filing
07 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Karen Tepichin, Attorney-in-Fact
Filing notes and source

Key filing fact

Steven P. Coen filed Form 4 for Ginkgo Bioworks Holdings, Inc. (DNA) on 21 Oct 2026.

Key facts

  • This page summarizes Steven P. Coen's Form 4 filing for Ginkgo Bioworks Holdings, Inc. (DNA).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 21 Oct 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 07 Oct 2026.
  • Current net transaction value: -$7,770.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001977441 Primary reporting owner

Coen Steven P.

Relationship
Chief Financial Officer
Address
C/O GINKGO BIOWORKS HOLDINGS, INC., 27 DRYDOCK AVENUE, BOSTON
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Signature date
21 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DNA transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+1,174
Change %
+2.4%
Price
Shares after
50,622
Date
16 Oct 2026
Ownership
Direct
Footnotes
F1
DNA transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+312
Change %
+0.62%
Price
Shares after
50,934
Date
16 Oct 2026
Ownership
Direct
Footnotes
F1
DNA transaction

Class A Common Stock

Sale

Transaction value
-$7,770
Shares
-766
Change %
-1.5%
Price
$10.14
Shares after
50,168
Date
19 Oct 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,174
Change %
-22%
Price
Shares after
4,122
Date
16 Oct 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,174
Exercise price
Footnotes
F1, F3
DNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-312
Change %
-10%
Price
Shares after
2,663
Date
16 Oct 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
312
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Footnote F2

Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

Footnote F3

The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

Footnote F4

The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

SEC remarks

Chief Financial Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .